Anchorage-independent transcription of the cyclin A gene induced by the E7 oncoprotein of human papillomavirus type 16

Journal of Virology

Volumn 72, Issue 3, 1998, Pages 2323-2334

  Schulze, Almut ^a   Mannhardt, Boris ^a   Zerfass Thome, Karin ^a   Zwerschke, Werner ^a   Jansen Dürr, Pidder ^a,b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b Abt 620   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN A; ONCOPROTEIN;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ARTICLE; CELL ADHESION; CELL CYCLE S PHASE; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; WART VIRUS;

EID: 0031887359     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.3.2323-2334.1998     Document Type: Article

References (71)

1. Arroyo, M., S. Bagchi, and P. Raychaudhuri. 1993. Association of the human papillomavirus type-16 E7 protein with the S-phase-specific E2F-cyclin-A complex. Mol. Cell. Biol. 13:6537-6546.
2. Assoian, R. K., and X. Y. Zhu. 1997. Cell anchorage and the cytoskeleton as partners in growth factor dependent cell cycle progression. Curr. Opin. Cell Biol. 9:93-98.
3. Baldin, V., J. Lukas, M. J. Marcote, M. Pagano, and G. Draetta. 1993. Cyclin D1 is a nuclear protein required for cell cycle progression in G1. Genes Dev. 7:812-821.
4. Banks, L., C. Edmonds, and K. H. Vousden. 1990. Ability of the HPV16 E7 protein to bind RB and induce DNA synthesis is not sufficient for efficient transforming activity in NIH3T3 cells. Oncogene 5:1383-1389.
5. Beijersbergen, R. L., and R. Bernards. 1996. Cell cycle regulation by the retinoblastoma family of growth inhibitory proteins. Biochim. Biophys. Acta 1287:103-120.
6. Bohmer, R. M., E. Scharf, and R. K. Assoian. 1996. Cytoskeletal integrity is required throughout the mitogen stimulation phase of the cell cycle and mediates the anchorage-dependent expression of cyclin D1. Mol. Biol. Cell 7:101-111.
7. Boyer, S. N., D. E. Wazer, and V. Band. 1996. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res. 56:4620-4624.
8. Buck, V., K. E. Allen, T. Sorensen, A. Bybee, E. M. Hijmans, P. M. Voorhoeve, R. Bernards, and N. B. Lathangue. 1995. Molecular and functional characterisation of E2F-5, a new member of the E2F family. Oncogene 11:31-38.
9. Chellappan, S., V. Kraus, B. Kroger, K. Münger, P. M. Howley, W. Phelps, and J. R. Nevins. 1992. Adenovirus E1A, simian virus 40 tumor antigen, and human papillomavirus E7 protein share the capacity to disrupt the interaction between transcription factor E2F and the retinoblastoma gene product. Proc. Natl. Acad. Sci. USA 89:4549-4553.
10. Davies, R., R. Hicks, T. Crook, J. Morris, and K. Vousden. 1993. Human papillomavirus type-16 E7 associates with a histone H1 kinase and with p107 through sequences necessary for transformation. J. Virol. 67:2521-2528.
11. 1 cyclin-dependent kinase activity. Genes Dev. 9:2873-2887.
12. Delaluna, S., M. J. Burden, C. W. Lee, and N. B. Lathangue. 1996. Nuclear accumulation of the E2F heterodimer regulated by subunit composition and alternative splicing of a nuclear localization signal. J. Cell Sci. 109:2443-2452.
13. Demers, G. W., E. Espling, J. B. Harry, B. G. Etscheid, and D. A. Galloway. 1996. Abrogation of growth arrest signals by human papillomavirus type 16 E7 is mediated by sequences required for transformation. J. Virol. 70:6862-6869.
14. Demers, G. W., S. A. Foster, C. L. Halbert, and D. A. Galloway. 1994. Growth arrest by induction of p53 in DNA damaged keratinocytes is bypassed by human papillomavirus 16 E7. Proc. Natl. Acad. Sci. USA 91:4382-4386.
15. Dynlacht, B., O. Flores, J. A. Lees, and E. Harlow. 1994. Differential regulation of E2F trans-activation by cyclin/cdk2 complexes. Genes Dev. 8:1772-1786.
16. Dyson, N., P. Guida, K. Münger, and E. Harlow. 1992. Homologous sequences in adenovirus E1A and human papillomavirus E7 proteins mediate interactions with the same set of cellular proteins. J. Virol. 66:6893-6902.
17. Edmonds, C., and K. Vousden. 1989. A point mutational analysis of human papillomavirus type 16 E7 protein. J. Virol. 63:2650-2656.
18. Fang, F., G. Orend, N. Watanabe, T. Hunter, and E. Ruoslahti. 1996. Dependence of cyclin E-CDK2 kinase activity on cell anchorage. Science 271: 499-502.
19. Funk, J., S. Waga, J. Harry, E. Espling, B. Stillman, and D. Galloway. 1997. Inhibition of cdk activity and PCNA-dependent DNA replication by p21 is blocked by interaction with the HPV-16 E7 oncoprotein. Genes Dev. 11: 2090-2100.
20. Guadagno, T., M. Ohtsubo, J. M. Roberts, and R. Assoian. 1993. A link between cyclin A expression and adhesion-dependent cell cycle progression. Science 262:1572-1575.
21. Hagen, G., J. Dennig, A. Preiss, M. Beato, and G. Suske. 1995. Functional analyses of the transcription factor Sp4 reveal properties distinct from Sp1 and Sp3. J. Biol. Chem. 270:24989-24994.
22. Hateboer, G., R. M. Kerkhoven, A. Shvarts, R. Bernards, and R. L. Beijersbergen. 1996. Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins. Genes Dev. 10:2960-2970.
23. Hawley-Nelson, P., K. H. Vousden, N. L. Hubbert, D. R. Lowy, and J. T. Schiller. 1989. HPV16 E6 and E7 proteins cooperate to immortalize human foreskin keratinocytes. EMBO J. 8:3905-3910.
24. Helin, K., C. L. Wu, A. R. Fattaey, J. A. Lees, B. D. Dynlacht, C. Ngwu, and E. Harlow. 1993. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev. 7:1850-1861.
25. Henglein, B., X. Chenivesse, J. Wang, D. Eick, and C. Brechot. 1994. Structure and cell cycle regulated transcription of the human cyclin A gene. Proc. Natl. Acad. Sci. USA 91:5490-5494.
26. Hickman, E. S., S. Bates, and K. H. Vousden. 1997. Perturbation of the p53 response by human papillomavirus type 16 E7. J. Virol. 71:3710-3718.
27. Hickman, E. S., S. M. Picksley, and K. H. Vousden. 1994. Cells expressing HPV16 E7 continue cell cycle progression following DNA damage induced p53 activation. Oncogene 9:2177-2181.
28. Hijmans, E. M., P. M. Voorhoeve, R. L. Begersbergen, L. J. Vantveer, and R. Bernards. 1995. E2F-5, a new E2F family member that interacts with p130 in vivo. Mol. Cell. Biol. 15:3082-3089.
29. Howe, J. A., M. Howell, T. Hunt, and J. W. Newport. 1995. Identification of a developmental timer regulating the stability of embryonic cyclin A and a new somatic A-type cyclin at gastrulation. Genes Dev. 9:1164-1176.
30. Jansen-Dürr, P., A. Meichle, P. Steiner, M. Pagano, K. Finke, J. Botz, J. Weßbecher, G. Draetta, and M. Eilers. 1993. Differential modulation of cyclin gene expression by MYC. Proc. Natl. Acad. Sci. USA 90:2547-2552.
31. Jewers, R., P. Hildebrandt, J. Ludlow, B. Kell, and D. McCance. 1992. Regions of HPV 16 E7 oncoprotein required for immortalization of human keratinocytes. J. Virol. 66:1329-1335.
32. Jones, D. L., R. M. Alani, and K. Münger. 1997. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21CIP1-mediated inhibition of cdk2. Genes Dev. 11:2101-2111.
33. 1 growth arrest pathway in cells expressing the human papillomavirus type 16 E7 oncoprotein. J. Virol. 71:2905-2912.
34. Kanda, T., A. Furuno, and K. Yoshiike. 1988. Human papillomavirus type 16 open reading frame E7 encodes a transforming gene for rat 3Y1 cells. J. Virol. 62:610-613.
35. Land, H, L. F. Parada, and R. A. Weinberg. 1983. Cellular oncogenes and multistep carcinogenesis. Science 222:771-778.
36. Lathangue, N. B. 1996. E2F and the molecular mechanisms of early cell-cycle control. Biochem. Soc. Trans. 24:54-59.
37. Lindeman, G. J., S. Gaubatz, D. M. Livingston, and D. Ginsberg. 1997. The suhcellular localization of E2F-4 is cell-cycle dependent. Proc. Natl. Acad. Sci. USA 94:5095-5100.
38. Lukas, J., H. Müller, J. Bartkova, D. Spitkovsky, A. Kjerulff, P. Jansen-Dürr, M. Strauss, and J. Bartek. 1994. DNA tumour viruses, oncoproteins and retinoblastoma gene mutations share the ability to relieve the cell's requirement for cyclin D1 function in G1. J. Cell Biol. 125:625-638.
39. Lukas, J., M. Pagano, Z. Staskova, G. Draetta, and J. Bartek. 1994. Cyclin D1 protein oscillates and is essential for cell cycle progression in human tumour cell lines. Oncogene 9:707-718.
40. Magae, J., C. L. Wu, S. Illenye, E. Harlow, and N. H. Heintz. 1996. Nuclear localization of DP and E2F transcription factors by heterodimeric partners and retinoblastoma protein family members. J. Cell Sci. 109:1717-1726.
41. Matsushime, H., D. E. Quelle, S. A. Shurtleff, M. Shibuya, C. J. Sherr, and J. Y. Kato. 1994. D-type cyclin-dependent kinase activity in mammalian cells. Mol. Cell. Biol. 14:2066-2076.
42. Mayol, X., J. Garriga, and X. Grana. 1995. Cell cycle-dependent phosphorylation of the retinoblastoma-related protein p130. Oncogene 11:801-808.
43. McIntyre, M. C., M. G. Frattini, S. R. Grossman, and L. A. Laimins. 1993. Human papillomavirus type-18 E7 protein requires intact Cys-X-X-Cys motifs for zinc binding, dimerization, and transformation but not for Rb binding. J. Virol. 67:3142-3150.
44. McIntyre, M. C., M. N. Ruesch, and L. A. Laimins. 1996. Human papillomavirus E7 oncoproteins bind a single form of cyclin E in a complex with cdk2 and p107. Virology 215:73-82.
45. 1 arrest induced by serum deprivation and by the cell cycle inhibitor p21. J. Virol. 71:3451-3457.
46. Münger, K., W. C. Phelps, V. Bubb, P. M. Howley, and R. Schlegel. 1989. The E6 and E7 genes of human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J. Virol. 63:4417-4421.
47. Nevins, J. R. 1992. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424-429.
48. Ohtani, K., J. Degregori, and J. R. Nevins. 1995. Regulation of the cyclin E gene bv transcription factor E2F1. Proc. Natl. Acad. Sci. USA 92:12146-12150.
49. 1-to-S phase transition. Mol. Cell. Biol. 15:2612-2624.
50. Pagano, M., M. Durst, S. Joswig, G. Draetta, and P. Jansen-Dürr. 1992. Binding of the human E2F transcription factor to the retinoblastoma protein but not to cyclin A is abolished in HPV-16-immortalized cells. Oncogene 7:1681-1686.
51. Pagano, M., R. Pepperkok, J. Lukas, V. Baldin, W. Ansorge, J. Bartek, and G. Draetta. 1993. Regulation of the human cell cycle by the Cdk2 protein kinase. J. Cell Biol. 121:101-111.
52. Phelps, W. C., S. Bagchi, J. A. Barnes, P. Raychaudhuri, V. Kraus, K. Münger, P. M. Howley, and J. R. Nevins. 1991. Analysis of trans activation byhuman papillomavirus tvpe 16 E7 and adenovirus 12S E1A suggests a common mechanism. J. Virol. 65:6922-6930.
53. Phelps, W. C., K. Münger, C. L. Yee, J. A. Barnes, and P. M. Howley. 1992. Structure-function analysis of the human papillomavirus type 16 E7 oncoprotein. J. Virol. 66:2418-2427.
54. Phelps, W. C., C. L. Yee, K. Münger, and P. M. Howley. 1988. The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A. Cell 53:539-547.
55. Kip1. Mol. Cell. Biol. 15:4347-4352.
56. Ruesch, M., and L. Laimins. 1997. Initiation of DNA synthesis by human papillomavirus E7 oncoproteins is resistant to p21-mediated inhibition of cyclin E-cdk2 activity. J. Virol. 71:5570-5578.
57. 56a. Schulze, A. Unpublished results.
58. Schulze, A., K. Zerfaß, D. Spitkovsky, J. Berges, S. Middendorp, P. Jansen-Dürr, and B. Henglein. 1995. Cell cycle regulation of cyclin A gene transcription is mediated by a variant E2F binding site. Proc. Natl. Acad. Sci. USA 92:11264-11268.
59. Schulze, A., K. Zerfass-Thome, J. Berges, S. Middendorp, P. Jansen-Dürr, and B. Henglein. 1996. Anchorage-dependent transcription of the cyclin A gene. Mol. Cell. Biol. 16:4632-4638.
60. Spitkovsky, D., A. Schulze, B. Boye, and P. Jansen-Dürr. 1997. Downregulation of cyclin A gene expression upon genotoxic stress correlates with reduced binding of free E2F to the promoter. Cell Growth Differ. 8:699-710.
61. Tani, K., M. C. Yoshida, H. Satoh, K. Mitamura, T. Noguchi, T. Tanaka, H. Fujii, and S. Miwa. 1988. Human M2-type pyruvate kinase: cDNA cloning, chromosomal assignment and expression in hepatoma. Gene 73:509-516.
62. Tommasino, M., J. P. Adamczewski, F. Carlotti, C. F. Barth, R. Manetti, M. Contorni, F. Cavalieri, T. Hunt, and L. Crawford. 1993. HPV16 E7 protein associates with the protein kinase p33CDK2 and cyclin A. Oncogene 8:195-202.
63. van den Heuvel, S., and E. Harlow. 1993. Distinct roles for cyclin-dependent kinases in cell cycle control. Science 262:2050-2054.
64. Wu, E. W., K. E. Clemens, D. V. Heck, and K. Munger. 1993. The human papillomavirus E7 oncoprotein and the cellular transcription factor E2F bind to separate sites on the retinoblastoma tumor suppressor protein. J. Virol. 67:2402-2407.
65. Zerfaß, K., L. Levy, C. Cremonesi, F. Ciccolini, P. Jansen-Dürr, L. Crawford, R. Ralston, and M. Tommasino. 1995. Cell cycle dependent disruption of E2F/p107 complexes by human papillomavirus type 16 E7. J. Gen. Virol. 76:1815-1820.
66. Zerfass, K., A. Schulze, D. Spitkovsky, V. Friedman, B. Henglein, and P. Jansen-Dürr. 1995. Sequential activation of cyclin E and cyclin A gene expression by human papillomavirus type 16 E7 through sequences necessary for transformation. J. Virol. 69:6389-6399.
67. KIP1 blocks cyclin E-dependent trans-activation of cyclin A gene expression. Mol. Cell. Biol. 17:407-415.
68. Zerfass-Thome, K., W. Zwerschke, B. Mannhardt, R. Tindle, J. Botz, and P. Jansen-Dürr. 1996. Inactivation of the cdk inhibitor p27KIP1 by the human papillomavirus type 16 E7 oncoprotein. Oncogene 13:2323-2330.
69. Zhu, X. Y., M. Ohtsubo, R. M. Bohmer, J. M. Roberts, and R. K. Assoian. 1996. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J. Cell Biol. 133:391-403.
70. zur Hausen, H. 1991. Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184:9-13.
71. zur Hausen, H., and A. Schneider. 1987. The role of papillomaviruses in human anogenital cancer, p. 245-263. In P. M. Howley and N. Salzman (ed.), The Papovaviridae: the papillomaviruses. Plenum Press, New York, N.Y.